0001127602-22-006327.txt : 20220223
0001127602-22-006327.hdr.sgml : 20220223
20220223163836
ACCESSION NUMBER: 0001127602-22-006327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PFREUNDSCHUH PETER P.
CENTRAL INDEX KEY: 0001585839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 22664443
MAIL ADDRESS:
STREET 1: C/O IMMUNOMEDICS, INC.
STREET 2: 300 THE AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-18
0001703647
Frequency Therapeutics, Inc.
FREQ
0001585839
PFREUNDSCHUH PETER P.
75 HAYDEN AVE
SUITE 300
LEXINGTON
MA
02421
1
Chief Financial Officer
Common Stock
2022-02-18
4
S
0
1404
3.877
D
10469
D
Common Stock
2022-02-22
4
S
0
1542
3.529
D
8927
D
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.79 to $3.95. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.40 to $3.76. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ James P. Abely, Attorney-in-Fact for Peter P. Pfreundschuh
2022-02-23